BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26042469)

  • 1. Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases.
    Korobkova EA
    Chem Res Toxicol; 2015 Jul; 28(7):1359-90. PubMed ID: 26042469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis.
    Modugno F; Knoll C; Kanbour-Shakir A; Romkes M
    Breast Cancer Res Treat; 2003 Dec; 82(3):191-7. PubMed ID: 14703066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis.
    Murray M
    Curr Drug Metab; 2006 Jan; 7(1):67-81. PubMed ID: 16454693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450: Polymorphisms and Roles in Cancer, Diabetes and Atherosclerosis.
    Elfaki I; Mir R; Almutairi FM; Duhier FMA
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2057-2070. PubMed ID: 30139042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450-mediated metabolism of estrogens and its regulation in human.
    Tsuchiya Y; Nakajima M; Yokoi T
    Cancer Lett; 2005 Sep; 227(2):115-24. PubMed ID: 16112414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 proteins: retention and distribution from the endoplasmic reticulum.
    Neve EP; Ingelman-Sundberg M
    Curr Opin Drug Discov Devel; 2010 Jan; 13(1):78-85. PubMed ID: 20047148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochromes P450: Role in Carcinogenesis and Relevance to Cancers.
    Abu-Bakar A; Tan BH; Halim H; Ramli S; Pan Y; Ong CE
    Curr Drug Metab; 2022 Aug; 23(5):355-373. PubMed ID: 35345986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyphenols as small molecular inhibitors of signaling cascades in carcinogenesis.
    Kang NJ; Shin SH; Lee HJ; Lee KW
    Pharmacol Ther; 2011 Jun; 130(3):310-24. PubMed ID: 21356239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoids and Cytochrome P450 Interactions.
    Zendulka O; Dovrtělová G; Nosková K; Turjap M; Šulcová A; Hanuš L; Juřica J
    Curr Drug Metab; 2016; 17(3):206-26. PubMed ID: 26651971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Underestimated reactions and regulation patterns of adrenal cytochromes P450.
    Bernhardt R; Neunzig J
    Mol Cell Endocrinol; 2021 Jun; 530():111237. PubMed ID: 33722664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450-activated prodrugs: targeted drug delivery.
    Huttunen KM; Mähönen N; Raunio H; Rautio J
    Curr Med Chem; 2008; 15(23):2346-65. PubMed ID: 18855665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases.
    Mitjavila MT; Moreno JJ
    Biochem Pharmacol; 2012 Nov; 84(9):1113-22. PubMed ID: 22858365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and developmental expression of the full complement of Cytochrome P450 genes in Zebrafish.
    Goldstone JV; McArthur AG; Kubota A; Zanette J; Parente T; Jönsson ME; Nelson DR; Stegeman JJ
    BMC Genomics; 2010 Nov; 11():643. PubMed ID: 21087487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450.
    Hodek P; Trefil P; Stiborová M
    Chem Biol Interact; 2002 Jan; 139(1):1-21. PubMed ID: 11803026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases.
    Navarro-Mabarak C; Camacho-Carranza R; Espinosa-Aguirre JJ
    Drug Metab Rev; 2018 May; 50(2):95-108. PubMed ID: 29451034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-Based High-Throughput Assays for Investigating Cytochrome P450 Enzyme-Mediated Drug-Drug Interactions.
    He R; Dai Z; Finel M; Zhang F; Tu D; Yang L; Ge G
    Drug Metab Dispos; 2023 Oct; 51(10):1254-1272. PubMed ID: 37349113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered cytochrome P450 activities and expression levels in the liver and intestines of the monosodium glutamate-induced mouse model of human obesity.
    Tomankova V; Liskova B; Skalova L; Bartikova H; Bousova I; Jourova L; Anzenbacher P; Ulrichova J; Anzenbacherova E
    Life Sci; 2015 Jul; 133():15-20. PubMed ID: 25998026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics.
    Strolin Benedetti M; Whomsley R; Baltes E
    Expert Opin Drug Metab Toxicol; 2006 Dec; 2(6):895-921. PubMed ID: 17125408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural dietary anti-cancer chemopreventive compounds: redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells.
    Nair S; Li W; Kong AN
    Acta Pharmacol Sin; 2007 Apr; 28(4):459-72. PubMed ID: 17376285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.